OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder
Richard C. Shelton, Sagar V. Parikh, Rebecca Law, et al.
Psychiatry Research (2020) Vol. 290, pp. 113017-113017
Open Access | Times Cited: 22

Showing 22 citing articles:

Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications
Alexandria Tartt, Madeline Mariani, René Hen, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 6, pp. 2689-2699
Open Access | Times Cited: 225

Depression, antidepressants and fall risk: therapeutic dilemmas—a clinical review
Eveline P. van Poelgeest, A. C. Pronk, Didi Rhebergen, et al.
European Geriatric Medicine (2021) Vol. 12, Iss. 3, pp. 585-596
Open Access | Times Cited: 73

CYP3A4∗22 Genotyping in Clinical Practice: Ready for Implementation?
Tessa A. M. Mulder, Ruben A.G. van Eerden, Mirjam de With, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 46

Polypharmacy and pharmacogenomics in high-acuity behavioral health care for autism spectrum disorder: A retrospective study
Sheldon R. Garrison, Sophie A. Schweinert, Matthew W. Boyer, et al.
Research Square (Research Square) (2025)
Closed Access

How Can Drug Metabolism and Transporter Genetics Inform Psychotropic Prescribing?
Beatriz Carvalho Henriques, Esther H. Yang, Diego L. Lapetina, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 35

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants
Chin B. Eap, Gerhard Gründer, Pierre Baumann, et al.
The World Journal of Biological Psychiatry (2021) Vol. 22, Iss. 8, pp. 561-628
Open Access | Times Cited: 30

Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
Farhana Islam, Victoria S. Marshe, Leen Magarbeh, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20

Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study
Liv S. Thiele, Kazi Ishtiak‐Ahmed, Janne Pia Thirstrup, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 870-870
Open Access | Times Cited: 15

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
Jeffrey R. Strawn, Ethan A. Poweleit, Chakradhara Rao S. Uppugunduri, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 17

The Utility of Pharmacogenetic-Guided Psychotropic Medication Selection for Pediatric Patients: A Retrospective Study
Merlin Ariefdjohan, Yee Ming Lee, Danielle L. Stutzman, et al.
Pediatric Reports (2021) Vol. 13, Iss. 3, pp. 421-433
Open Access | Times Cited: 11

Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population
Pari Faraj, Tore Haslemo, Jenny Phung Tran, et al.
British Journal of Clinical Pharmacology (2024)
Open Access | Times Cited: 1

Molecular Mechanisms Associated with Antidepressant Treatment on Major Depression
Lívia Ramos-da-Silva, Pamela T. Carlson, Lícia C. Silva-Costa, et al.
Complex Psychiatry (2021) Vol. 7, Iss. 3-4, pp. 49-59
Open Access | Times Cited: 10

Combinatorial pharmacogenomic algorithm is predictive of sertraline metabolism in patients with major depressive disorder
Sagar V. Parikh, Rebecca Law, Daniel Hain, et al.
Psychiatry Research (2021) Vol. 308, pp. 114354-114354
Open Access | Times Cited: 5

Real-world experience of using combinatorial pharmacogenomic test in children and adolescents with depression and anxiety
Anjali Dagar, Suneela Cherlopalle, Veena Ahuja, et al.
Journal of Psychiatric Research (2021) Vol. 146, pp. 83-86
Closed Access | Times Cited: 4

Citalopram and Escitalopram
Richard C. Shelton
American Psychiatric Association Publishing eBooks (2024)
Closed Access

Pharmacogenomic augmented machine learning in electronic health record alerts: A health system‐wide usability survey of clinicians
Caroline W. Grant, Jean Marrero‐Polanco, Jeremiah B. Joyce, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 10
Open Access

Pharmacogenomic Profiling of Pediatric Patients on Psychotropic Medications in an Emergency Department
Pallavi Ghosh, Jesse Martinez, Nipam Shah, et al.
Pediatric Emergency Care (2022) Vol. 39, Iss. 1, pp. 6-12
Open Access | Times Cited: 2

Plasma Concentrations and Cardiovascular Effects of Citalopram Enantiomers after Oral vs. Infusion Citalopram Therapy in Dextromethorphan- and Mephenytoin-Phenotyped Patients with Major Depression
Pierre Baumann, Gilles Bertschy, F Ramseier, et al.
Therapeutic Drug Monitoring (2020) Vol. 43, Iss. 3, pp. 436-442
Closed Access | Times Cited: 1

Pharmacogenetics
Kewal K. Jain
Springer eBooks (2020), pp. 115-152
Closed Access | Times Cited: 1

Pharmacogenetic Algorithms
Bernard Esquivel, Cristina Verzosa, Hagit Katzov-Eckert, et al.
Springer eBooks (2023), pp. 105-131
Closed Access

Personalized Therapy of Psychiatric Disorders
Kewal K. Jain
Springer eBooks (2020), pp. 263-277
Closed Access

Page 1

Scroll to top